159 related articles for article (PubMed ID: 31094866)
1. The Lived Experience of Antiretroviral Therapy for Pregnant Women: Antiretroviral Therapy Adherence as a Balancing Act.
Shore JE; Paun O; Vonderheid SC
J Assoc Nurses AIDS Care; 2020; 31(4):448-456. PubMed ID: 31094866
[TBL] [Abstract][Full Text] [Related]
2. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study.
Buregyeya E; Naigino R; Mukose A; Makumbi F; Esiru G; Arinaitwe J; Musinguzi J; Wanyenze RK
BMC Pregnancy Childbirth; 2017 Mar; 17(1):94. PubMed ID: 28320347
[TBL] [Abstract][Full Text] [Related]
3. Determinants of suboptimal adherence and elevated HIV viral load in pregnant women already on antiretroviral therapy when entering antenatal care in Cape Town, South Africa.
Brittain K; Remien RH; Mellins CA; Phillips TK; Zerbe A; Abrams EJ; Myer L
AIDS Care; 2018 Dec; 30(12):1517-1523. PubMed ID: 30047287
[TBL] [Abstract][Full Text] [Related]
4. The Video intervention to Inspire Treatment Adherence for Life (VITAL Start): protocol for a multisite randomized controlled trial of a brief video-based intervention to improve antiretroviral adherence and retention among HIV-infected pregnant women in Malawi.
Kim MH; Tembo TA; Mazenga A; Yu X; Myer L; Sabelli R; Flick R; Hartig M; Wetzel E; Simon K; Ahmed S; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Markham C; Ciaranello A; Abrams EJ
Trials; 2020 Feb; 21(1):207. PubMed ID: 32075677
[TBL] [Abstract][Full Text] [Related]
5. Understanding Antiretroviral Treatment Adherence Among HIV-Positive Women at Four Postpartum Time Intervals: Qualitative Results from the Kabeho Study in Rwanda.
Gill MM; Umutoni A; Hoffman HJ; Ndatimana D; Ndayisaba GF; Kibitenga S; Mugwaneza P; Asiimwe A; Bobrow EA
AIDS Patient Care STDS; 2017 Apr; 31(4):153-166. PubMed ID: 28358624
[TBL] [Abstract][Full Text] [Related]
6. The lived experiences of rural women diagnosed with the human immunodeficiency virus in the antenatal period.
Fords GM; Crowley T; van der Merwe AS
SAHARA J; 2017 Dec; 14(1):85-92. PubMed ID: 28949277
[TBL] [Abstract][Full Text] [Related]
7. What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
Mukose AD; Bastiaens H; Makumbi F; Buregyeya E; Naigino R; Musinguzi J; Van Geertruyden JP; Wanyenze RK
PLoS One; 2021; 16(5):e0251181. PubMed ID: 33951109
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
Omonaiye O; Kusljic S; Nicholson P; Manias E
BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
[TBL] [Abstract][Full Text] [Related]
9. Identifying barriers to ART initiation and adherence: An exploratory qualitative study on PMTCT in Zambia.
Kanguya T; Koyuncu A; Sharma A; Kusanathan T; Mubanga M; Chi BH; Vinikoor MJ; Mubiana-Mbewe M
PLoS One; 2022; 17(1):e0262392. PubMed ID: 35025923
[TBL] [Abstract][Full Text] [Related]
10. 'I wanted to safeguard the baby': a qualitative study to understand the experiences of Option B+ for pregnant women and the potential implications for 'test-and-treat' in four sub-Saharan African settings.
McLean E; Renju J; Wamoyi J; Bukenya D; Ddaaki W; Church K; Zaba B; Wringe A
Sex Transm Infect; 2017 Jul; 93(Suppl 3):. PubMed ID: 28736391
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of lifelong treatment among HIV-positive pregnant and breastfeeding women (Option B+) in selected health facilities in Zimbabwe: a qualitative study.
Chadambuka A; Katirayi L; Muchedzi A; Tumbare E; Musarandega R; Mahomva AI; Woelk G
BMC Public Health; 2017 Jul; 18(1):57. PubMed ID: 28743251
[TBL] [Abstract][Full Text] [Related]
12. VITAL Start: Video-Based Intervention to Inspire Treatment Adherence for Life-Pilot of a Novel Video-Based Approach to HIV Counseling for Pregnant Women Living with HIV.
Kim MH; Ahmed S; Tembo T; Sabelli R; Flick R; Yu X; Mazenga A; Le Blond H; Simon K; Hartig M; Wetzel E; Nyirenda R; Kazembe PN; Mphande M; Mkandawire A; Chitani MJ; Abrams EJ
AIDS Behav; 2019 Nov; 23(11):3140-3151. PubMed ID: 31410618
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa.
Adeniyi OV; Ajayi AI; Ter Goon D; Owolabi EO; Eboh A; Lambert J
BMC Infect Dis; 2018 Apr; 18(1):175. PubMed ID: 29653510
[TBL] [Abstract][Full Text] [Related]
14. Self-Reported Long-Term Antiretroviral Adherence: A Longitudinal Study Among HIV Infected Pregnant Women in Mpumalanga, South Africa.
Ramlagan S; Rodriguez VJ; Peltzer K; Ruiter RAC; Jones DL; Sifunda S
AIDS Behav; 2019 Sep; 23(9):2576-2587. PubMed ID: 31228026
[TBL] [Abstract][Full Text] [Related]
15. Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.
Myer L; Phillips TK
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S115-S122. PubMed ID: 28498180
[TBL] [Abstract][Full Text] [Related]
16. Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.
Wesevich A; Hosseinipour MC; Golin CE; McGrath N; Tsidya M; Chimndozi L; Bhushan N; Hoffman I; Miller WC; Rosenberg NE
AIDS Care; 2020 Feb; 32(2):170-174. PubMed ID: 31238717
[TBL] [Abstract][Full Text] [Related]
17. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living With HIV in the Context of Option B+ in Zimbabwe.
Erlwanger AS; Joseph J; Gotora T; Muzunze B; Orne-Gliemann J; Mukungunugwa S; Farley T; Mangwiro AZ
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2():S198-S206. PubMed ID: 28498190
[TBL] [Abstract][Full Text] [Related]
18. Post Option B+ implementation programme in Nigeria: Determinants of adherence of antiretroviral therapy among pregnant women with HIV.
Omonaiye O; Kusljic S; Nicholson P; Mohebbi M; Manias E
Int J Infect Dis; 2019 Apr; 81():225-230. PubMed ID: 30790723
[TBL] [Abstract][Full Text] [Related]
19. Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women.
Mellins CA; Chu C; Malee K; Allison S; Smith R; Harris L; Higgins A; Zorrilla C; Landesman S; Serchuck L; Larussa P
AIDS Care; 2008 Sep; 20(8):958-68. PubMed ID: 18608073
[TBL] [Abstract][Full Text] [Related]
20. Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.
Lumbantoruan C; Kermode M; Giyai A; Ang A; Kelaher M
PLoS One; 2018; 13(6):e0198329. PubMed ID: 29912960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
